Seeking Alpha

Illumina (ILMN) agrees to acquire Verinata Health, a provider of non-invasive tests for the...

Illumina (ILMN) agrees to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for $350M upfront and as much as $100M in milestone payments through 2015. Illumina expects the deal to dilute its EPS by $0.20 in 2013 and become accretive from next year. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs